ProfileGDS4718 / 225291_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 83% 82% 85% 85% 97% 95% 86% 79% 87% 90% 77% 94% 96% 95% 90% 86% 97% 95% 90% 87% 86% 86% 88% 89% 93% 82% 94% 83% 95% 93% 96% 81% 84% 92% 96% 96% 88% 87% 86% 87% 94% 91% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9737688
GSM549102patient 115, normal, homogenized [OPG study]8.1606683
GSM549104patient 119, normal, homogenized [OPG study]8.2128582
GSM549108patient 138, normal, homogenized [OPG study]8.3923585
GSM549119patient 077, normal, homogenized [OPG study]8.4114585
GSM549133patient 032, cancer, homogenized [OPG study]11.05197
GSM549139patient 042, cancer, homogenized [OPG study]10.258195
GSM549099patient 107, normal, homogenized [OPG study]8.5761786
GSM549109patient 139, normal, homogenized [OPG study]7.6480679
GSM549110patient 046, normal, homogenized [OPG study]8.7328387
GSM549114patient 063, normal, homogenized [OPG study]9.3770190
GSM549122patient 082, normal, homogenized [OPG study]7.5652677
GSM549134patient 033, cancer, homogenized [OPG study]10.017994
GSM549136patient 036, cancer, homogenized [OPG study]10.408896
GSM549140patient 044, cancer, homogenized [OPG study]10.117195
GSM549111patient 047, normal, homogenized [OPG study]9.2242190
GSM549113patient 057, normal, homogenized [OPG study]8.7123386
GSM549132patient 031, cancer, homogenized [OPG study]10.676797
GSM549137patient 038, cancer, homogenized [OPG study]10.032695
GSM549142patient 047, cancer, homogenized [OPG study]8.7616290
GSM549100patient 110, normal, homogenized [OPG study]8.6955787
GSM549107patient 135, normal, homogenized [OPG study]8.6091286
GSM549115patient 068, normal, homogenized [OPG study]8.8270286
GSM549116patient 072, normal, homogenized [OPG study]9.0043188
GSM549120patient 078, normal, homogenized [OPG study]9.0698289
GSM549131patient 030, cancer, homogenized [OPG study]9.7980893
GSM549118patient 074, normal, homogenized [OPG study]8.0551582
GSM549129patient 027, cancer, homogenized [OPG study]9.8428694
GSM549123patient 088, normal, homogenized [OPG study]8.2410583
GSM549124patient 006, cancer, homogenized [OPG study]10.12395
GSM549126patient 015, cancer, homogenized [OPG study]9.6110493
GSM549128patient 025, cancer, homogenized [OPG study]10.44496
GSM549103patient 117, normal, homogenized [OPG study]7.7973381
GSM549117patient 073, normal, homogenized [OPG study]8.4432284
GSM549138patient 041, cancer, homogenized [OPG study]9.5196692
GSM549141patient 045, cancer, homogenized [OPG study]10.550696
GSM549130patient 028, cancer, homogenized [OPG study]10.29596
GSM549101patient 111, normal, homogenized [OPG study]8.7934688
GSM549105patient 128, normal, homogenized [OPG study]8.7115187
GSM549106patient 134, normal, homogenized [OPG study]8.7256686
GSM549112patient 048, normal, homogenized [OPG study]8.8307687
GSM549125patient 011, cancer, homogenized [OPG study]9.984394
GSM549127patient 024, cancer, homogenized [OPG study]9.2334691
GSM549135patient 035, cancer, homogenized [OPG study]11.196698